Full-Time

Microbiology Solutions Architect

Msa, Capital Sales

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Develops and sells medical devices and diagnostics

Compensation Overview

$130k - $255k/yr

Senior

Salt Lake City, UT, USA + 7 more

More locations: Seattle, WA, USA | San Francisco, CA, USA | Los Angeles, CA, USA | Phoenix, AZ, USA | Denver, CO, USA | Portland, OR, USA | San Diego, CA, USA

Hybrid

Territory includes: AZ, CA, NV, UT, CO, WY, MT, ID, OR & WA. Minimum of 4 days in-office presence required.

Category
Biology Lab & Research
Sales Engineering
Sales & Solution Engineering
Biology & Biotech
Required Skills
Financial analysis
PowerPoint/Keynote/Slides
Requirements
  • Minimum Bachelors degree in Life Sciences, biological areas, business or related field.
  • Minimum 5 years documented sales success in large dollar capital equipment sales.
  • Strong knowledge of large capital equipment sales in complex accounts (hospitals and reference labs).
  • Solution selling and leading without authority in a highly matrix organization.
  • Knowledge of selling process and the components to build / maintain customer loyalty.
  • Preparation, presentation and closing skills to include direct sales, use of distribution channel and/or team selling approach.
  • Strong organizational skills. Territory management, account assessment and relationship development. Analytical with financial orientation applicable to contract proposals and profitability, budget, and expense management.
  • Ability to develop markets for new technology and new medical practices.
  • Excellent communication skills and interpersonal interaction required.
  • Computer and new technology savvy - working knowledge of MS Office applications, PowerPoint, SharePoint, iPhone, Skype and / or other connectivity devices.
  • Ability to travel 50-75% of the time.
  • Must possess and maintain a valid state-issued driver's license with 3 years of consecutive driving history and meet BD's auto safety standards.
Responsibilities
  • Develop and implement a strategic account sales plan which includes multiple external collaborators in the hospital and reference lab environment to achieve sales of the BD Kiestra product line and all relevant pull through products.
  • Leading without direct authority of the local account teams; partnership with the Strategic Customer Group Vice Presidents, Marketing, Distribution, Applications, Service and Project Management.
  • Effectively deploying clinically relevant product features / benefits with economic justification using existing selling tools as well as crafting new tools specific to each customer situation to define the value of our product offerings.
  • Manages and coordinates all decision makers to arrive at a contractual purchase agreement for BD Kiestra and related products.
  • Responsible for maintaining realized revenue stream and ensuring customer satisfaction through consistent customer contact.
  • Attain or exceed the overall sales plan for the designated platform of product; maximize the potential of all contract terms realized between BD and customer.
  • The Microbiology Solutions Architect will need to have a command of BD's long term strategic direction and be able to communicate that strategy to the customer. Using this knowledge, demonstrate the value proposition of the entire product portfolio to be consistent with the needs of the customer.
  • Manage the sales process consisting of the clinical laboratory (molecular, microbiology, virology) which includes Medical Technologists, Microbiology Managers/Directors, Pathology, Anti-Microbial Stewardship Councils, epidemiologists and infectious disease clinicians; and hospital administration in the assigned territory.
  • Foster existing, and establish new, relationships with clinical lab Administration and executive leadership in the respective territories.

BD (Becton, Dickinson and Company) is a global medical technology firm that focuses on improving health through various segments such as BD Medical, BD Life Sciences, and BD Interventional. The company develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic products to a diverse clientele, including hospitals and healthcare providers across multiple regions including North America, Europe, Asia, and Latin America. BD's products are designed to enhance patient outcomes, reduce healthcare costs, and improve safety and operational efficiency in healthcare delivery. What sets BD apart from its competitors is its comprehensive approach to healthcare solutions, which aims to expand access to medical services while ensuring high standards of safety and efficiency. The company's goal is to advance healthcare by providing innovative solutions that support medical discovery and diagnostics.

Company Size

10,001+

Company Stage

IPO

Headquarters

Eysins, Switzerland

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for telehealth boosts BD's remote patient monitoring devices.
  • Personalized medicine growth increases need for BD's advanced diagnostic tools.
  • Wearable medical devices market expansion offers BD new technology opportunities.

What critics are saying

  • Increased competition from emerging markets may impact BD's market share.
  • Rapid technological advancements require continuous R&D investment from BD.
  • Global talent shortage could affect BD's innovation and operational efficiency.

What makes Becton Dickinson unique

  • BD's $1.2B investment enhances syringe and drug delivery manufacturing capabilities.
  • Acquisition of Cubex LLC's assets boosts BD's cloud-based medical software offerings.
  • BD's global presence spans North America, EMEA, Greater Asia, and Latin America.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...